2021 Radiopharmaceutical Therapy muBenign uye Malignant Zvirwere: Radiotheragnostic Practicum
UCHAWANYA KOSHESA VIA HERE HUPENYU KUSVIRA DZIDZISO (FAST SPEED) PASI PAYMENT
Iyi inoenderera mberi chiitiko chedzidzo inoongorora maitiro akanakisa mumunda uri kukura we radiotheragnostics (aka theranostics kana theragnostics) yezvirwere zvakaipa uye zvakaipa, kutanga nezvakakosha uye kuwedzera kuwedzera maitiro epamberi emakiriniki. Kuongororwa kwemaitiro ekurapa akave akave akagadziridzwa mushe pamwe neazvino maitiro akaverengerwa akaverengerwa. Iyo nyanzvi fakitori inokurukura kukwidziridzwa kweiyo radiotheragnostic maitiro ekushandisa kwakanakisa kweakasiyana ma radiopharmaceuticals mune ano maitiro ekuchengetwa kwehurongwa masisitimu, zvese zvedzidzo uye zvakavanzika maitiro masisitimu.
Vatereri vakanangwa
Musangano uyu wakagadzirirwa varapi venyukireya varapi, venyukireya radiologists, oncologists, hutano physicists, uye radiopharmacists
Zvinangwa zvechikoro
Pakupera kweichi chiitiko cheCME, vanyori vanofanirwa kukwanisa ku:
- Musiyano uripo pakati peiyo radiotheragnostic nzira uye nedzimwe dzakasiyana pfungwa dzichitungamira kurapa kuendesa radiation kubva kune dzakanangwa matishu nechinangwa chekuvandudza mhedzisiro yehutano.
- Iyo yakanakisa yekurapa maitiro inoswedera kune hyperthyroidism uye zvimwe benign utachiona zvirwere, zvichibva pane humbowo uye / kana kurira kurapa kwekurapa.
- Iyo yakanakisa yekurapa tsika nzira yekusiyanisa utachiona carcinoma, zvichibva pane humbowo uye / kana kurira kurapa kwekutonga
- Iwo akanakisa mashandisiro eY-90 Ibritumomab Tiuxetan yekurapa lymphoma.
- Iwo akanakisa mashandisirwo eI-131 Iobenguane kuongororwa kwekufungidzira uye kurapwa kwePheochromocytoma uye Paraganglioma.
- Iwo akanakisa mashandisiro eY-90 Resin uye Girazi Microspheres kune radioembolization kurapwa kwechiropa chegomarara.
- Iwo akanakisa mashandisirwo eGa-68 Dotatate Imaging uye Lu-177 Dotatate kurapwa kwemamota aneuroendocrine.
- Iyo nzira yakanakisa yekuongorora yekufungidzira kweanowanzoitika uye metastatic kenza yeprostate.
- Iyo yakanakisa nzira yekurapa kwemabhonzo metastatic chirwere uchishandisa akasiyana Bone-Kutsvaga radiopharmaceuticals.
- Iyo mienzaniso inoshanda yekuongororwa kweasina kunyorwa kenza ye radiotheragnostics-based bvunzo.
- Nzira dzakanakisa dzekuvaka radiotheragnostic tsika mumasangano ezvidzidzo.
- Yakanakisa nzira yekuvaka radiotheragnostic tsika mune zvakavanzika maitiro masetisheni.
Misoro Uye Vatauri:
Nhoroondo & Maitiro eRadioiodine Therapy muHyperthyroidism
Maka Tulchinsky, MD, FACNM, FSNMMI, CCD
Ongororo yeTargeted Therapy - Zvidzidzo Zvakadzidziswa
Terence Z. Wong, MD, Ph.D.
Radioiodine Therapy: Kazhinji Benign Thyroid Mamiriro
Maka Tulchinsky, MD, FACNM, FSNMMI, CCD
I-131 Iobenguane Kufananidza & Therapy yePheochromocytoma / Paraganglioma
Erik S. Mittra MD, Ph.D.
Radioiodine muTiroid Cancer - Basics
Maka Tulchinsky, MD, FACNM, FSNMMI, CCD
Radioiodine muTyroid Cancer - Yepamberi
Maka Tulchinsky, MD, FACNM, FSNMMI, CCD
Radioembolization Therapy neY-90 Resin uye Girazi Microspheres
Terence Z. Wong, MD, Ph.D.
Ga-68 / Lu-177 Dotatate Kufungidzira / Therapy yeNeuroendocrine Tumors
Erik S. Mittra MD, Ph.D.
Kuongorora Kufungidzira Kwekudzokorora uye Metastatic Prostate Cancer
Samuel Mehr, MD
Therapy yeSkeletal Metastatic Chirwere neBone-Kutsvaga Agents
Terence Z. Wong, MD, Ph.D.
Radiotheragnostics muProstate Kenza
Terence Z. Wong, MD, Ph.D.
Yakakosha Miedzo muUSA yeUp-uye-Kuuya Radiotheragnostics
Erik S. Mittra MD, Ph.D.
Mikana yeSomatostatin Receptor Targeting muAvid Cancers
Samuel Mehr, MD
Kuvaka Nyukireya Mishonga Therapy Chirongwa muChikoro Kudzidzira
Erik S. Mittra MD, Ph.D.
Kuvaka Nyukireya Mishonga Therapy Chirongwa mune Yakavanzika Maitiro
Samuel Mehr, MD